Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
NVIDIA AI Podcast
00:00
Is There a Difference Between Machine Learning and Recruiting?
Tobos: Can you kind of foster that learning internally? Yps, we've spent a lot of energies with the training of people and teaching people emenology. And iianiwe also have a bit of that iision we just really throa itl to the tool and have them learn stuff like very fast. Faguets today is louis volock,. Louis is copounder and cto at immune, a company that is bringing together machine learning and biology to map the human immune system. He says they leverage technology and science to find new therapeutics for diseases such as cancer or heart disease.
Transcript
Play full episode
